| Product Code: ETC200142 | Publication Date: May 2022 | Updated Date: Jul 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 60 | No. of Figures: 40 | No. of Tables: 7 |
The Vietnam Nuclear Medicine Radioisotopes Market was estimated at USD 449 Million in 2025 and is projected to reach USD 634 Million by 2032, growing at a CAGR of 5.1% from 2026 to 2032. This growth trajectory is fueled by an expanding healthcare infrastructure and the increasing utilization of radioisotopes for diagnostic imaging and cancer treatment. As healthcare professionals gain a deeper understanding of the benefits of nuclear medicine, its integration into routine diagnostic and therapeutic practices becomes more pronounced.
This graph highlights how the Vietnam Nuclear Medicine Radioisotopes Market has steadily grown over the years, supported by major growth factors.

The table below presents the year‑wise growth rates along with the key drivers influencing the market
| Year | Growth Rate | Major Drivers |
| 2021 | 3.1% | Rising healthcare infrastructure investments |
| 2022 | 2.7% | Increased public health awareness campaigns |
| 2023 | 8.0% | Growing demand for diagnostics technology |
| 2024 | 5.3% | Expansion of healthcare facilities network |
| 2025 | 6.3% | Advancements in imaging technology applications |
| 2026 | 7.9% | Surge in patient population growth |
| 2027 | 7.7% | Enhanced research funding allocations |
| 2028 | 6.6% | Development of strategic partnerships initiatives |
| 2029 | 6.4% | Increase in international collaborations |
| 2030 | 5.6% | Focus on preventive healthcare measures |
| 2031 | 5.9% | Strengthening regulatory frameworks support |
| 2032 | 5.8% | Emergence of innovative treatment modalities |
Note: Market size estimations and growth projections presented in this report are based on 6Wresearch's proprietary forecasting methodology, utilizing the latest available industry data, government publications, and primary research inputs.
The landscape of nuclear medicine in Vietnam is evolving rapidly, characterized by a significant rise in the use of radioisotopes. This shift is largely attributed to advancements in medical technology and an increasing prevalence of chronic diseases, requiring more precise diagnostic tools and treatment options.
Moreover, the nation's healthcare system is continuously growing, enhancing access to nuclear medicine services across various regions. As hospitals and clinics expand their capabilities, the demand for reliable and effective radioisotope applications rises, underlining their importance in modern healthcare.
While the Vietnam Nuclear Medicine Radioisotopes market shows substantial promise, several significant restraints inhibit its full potential. Regulatory frameworks governing the use and handling of radioactive materials necessitate stringent adherence, often requiring significant investment from facilities to meet international standards. Moreover, the specialized nature of nuclear medicine demands a skilled workforce and advanced infrastructure, which may not be uniformly available across the nation, creating disparities in access to these vital medical services.
A notable trend is the increasing focus on personalized medicine, which is bolstering the demand for radioisotopes tailored to individual patient needs. Additionally, technological advancements, such as improved imaging techniques and radioisotope production methods, are enhancing efficiency and safety in medical applications. The rise of telemedicine is also influencing the market, as remote consultations facilitate timely diagnostics and treatment planning, thereby expanding the reach of nuclear medicine services.
The Vietnam Nuclear Medicine Radioisotopes market presents various growth opportunities, particularly in expanding applications beyond oncology, such as cardiology and neurology. Collaborations with international organizations for knowledge exchange and technology transfer can enhance local expertise and infrastructure. Moreover, the growing emphasis on health diagnostics and preventative care creates a fertile ground for investment in advanced radioisotope production technologies and distribution networks.
The Vietnamese government is actively promoting the development of nuclear medicine as part of its broader healthcare strategy. Initiatives aimed at enhancing healthcare infrastructure include funding for advanced medical facilities and technology upgrades. Additionally, policies that encourage public-private partnerships are creating avenues for investment in nuclear medicine research and development, supporting the growth of the radioisotope market.
Looking ahead to 2026-2032, the Vietnam Nuclear Medicine Radioisotopes market is poised for significant transformation. The increasing integration of nuclear medicine into standard healthcare practices will likely enhance diagnostic accuracy and treatment efficacy. Furthermore, as awareness of the therapeutic benefits of radioisotopes grows, they will become increasingly recognized as essential tools in comprehensive patient care strategies.
Recent developments in the Vietnam Nuclear Medicine Radioisotopes market indicate a shift toward more innovative applications and improved production techniques. Stakeholders are investing in advanced research initiatives to explore new radiopharmaceuticals and enhance the safety of radioisotope handling. Furthermore, there is a growing focus on training healthcare professionals in nuclear medicine applications, ensuring that the workforce is equipped to meet future demands.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Vietnam Nuclear Medicine Radioisotopes Market Overview |
3.1 Vietnam Country Macro Economic Indicators |
3.2 Vietnam Nuclear Medicine Radioisotopes Market Revenues & Volume, 2022 & 2032F |
3.3 Vietnam Nuclear Medicine Radioisotopes Market - Industry Life Cycle |
3.4 Vietnam Nuclear Medicine Radioisotopes Market - Porter's Five Forces |
3.5 Vietnam Nuclear Medicine Radioisotopes Market Revenues & Volume Share, By Types, 2022 & 2032F |
3.6 Vietnam Nuclear Medicine Radioisotopes Market Revenues & Volume Share, By Application, 2022 & 2032F |
4 Vietnam Nuclear Medicine Radioisotopes Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer and other chronic diseases requiring nuclear medicine diagnostics and treatments |
4.2.2 Growing investments in healthcare infrastructure and technology in Vietnam |
4.2.3 Rising awareness about the benefits of nuclear medicine radioisotopes for accurate diagnosis and treatment |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements and safety concerns associated with handling radioactive materials |
4.3.2 Limited availability of skilled professionals in the field of nuclear medicine |
4.3.3 High costs associated with the procurement and maintenance of nuclear medicine equipment |
5 Vietnam Nuclear Medicine Radioisotopes Market Trends |
6 Vietnam Nuclear Medicine Radioisotopes Market, By Types |
6.1 Vietnam Nuclear Medicine Radioisotopes Market, By Types |
6.1.1 Overview and Analysis |
6.1.2 Vietnam Nuclear Medicine Radioisotopes Market Revenues & Volume, By Types, 2022-2032F |
6.1.3 Vietnam Nuclear Medicine Radioisotopes Market Revenues & Volume, By Technetium-99m (Tc-99m), 2022-2032F |
6.1.4 Vietnam Nuclear Medicine Radioisotopes Market Revenues & Volume, By Thallium-201 (Tl-201), 2022-2032F |
6.1.5 Vietnam Nuclear Medicine Radioisotopes Market Revenues & Volume, By Iodine (I-123), 2022-2032F |
6.1.6 Vietnam Nuclear Medicine Radioisotopes Market Revenues & Volume, By Fluorine-18, 2022-2032F |
6.1.7 Vietnam Nuclear Medicine Radioisotopes Market Revenues & Volume, By Rubidium-82 (Rb-82), 2022-2032F |
6.1.8 Vietnam Nuclear Medicine Radioisotopes Market Revenues & Volume, By Iodine-131 (I-131), 2022-2032F |
6.1.9 Vietnam Nuclear Medicine Radioisotopes Market Revenues & Volume, By Others, 2022-2032F |
6.1.10 Vietnam Nuclear Medicine Radioisotopes Market Revenues & Volume, By Others, 2022-2032F |
6.2 Vietnam Nuclear Medicine Radioisotopes Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Vietnam Nuclear Medicine Radioisotopes Market Revenues & Volume, By Oncology, 2022-2032F |
6.2.3 Vietnam Nuclear Medicine Radioisotopes Market Revenues & Volume, By Cardiology, 2022-2032F |
6.2.4 Vietnam Nuclear Medicine Radioisotopes Market Revenues & Volume, By Thyroid, 2022-2032F |
6.2.5 Vietnam Nuclear Medicine Radioisotopes Market Revenues & Volume, By Neurology, 2022-2032F |
6.2.6 Vietnam Nuclear Medicine Radioisotopes Market Revenues & Volume, By Others, 2022-2032F |
7 Vietnam Nuclear Medicine Radioisotopes Market Import-Export Trade Statistics |
7.1 Vietnam Nuclear Medicine Radioisotopes Market Export to Major Countries |
7.2 Vietnam Nuclear Medicine Radioisotopes Market Imports from Major Countries |
8 Vietnam Nuclear Medicine Radioisotopes Market Key Performance Indicators |
8.1 Number of nuclear medicine procedures conducted annually in Vietnam |
8.2 Investment in research and development of new radioisotopes and technologies |
8.3 Adoption rate of nuclear medicine practices in healthcare facilities |
8.4 Government funding allocated to nuclear medicine research and infrastructure development |
8.5 Number of partnerships and collaborations between local and international players in the nuclear medicine industry |
9 Vietnam Nuclear Medicine Radioisotopes Market - Opportunity Assessment |
9.1 Vietnam Nuclear Medicine Radioisotopes Market Opportunity Assessment, By Types, 2022 & 2032F |
9.2 Vietnam Nuclear Medicine Radioisotopes Market Opportunity Assessment, By Application, 2022 & 2032F |
10 Vietnam Nuclear Medicine Radioisotopes Market - Competitive Landscape |
10.1 Vietnam Nuclear Medicine Radioisotopes Market Revenue Share, By Companies, 2025 |
10.2 Vietnam Nuclear Medicine Radioisotopes Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here